SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes

Diabetologia

Volumn 44, Issue 10, 2001, Pages 1258-1267

  Sasaoka, T ^a   Hori, H ^a   Wada, T ^a   Ishiki, M ^a   Haruta, T ^a   Ishihara, H ^a   Kobayashi, M ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

5 phosphatase; Akt; Glycogen synthesis; Insulin; PI3 kinase; SHIP2

Indexed keywords

GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; INOSITOL PHOSPHATASE 2; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; GLUCOSE HOMEOSTASIS; GLYCOGEN SYNTHESIS; INSULIN SENSITIVITY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOVIRIDAE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARBON RADIOISOTOPES; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC VECTORS; GLUCOSE; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INSULIN; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0034775501     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100645     Document Type: Article

References (35)

1. Diverse signalling pathways in the cellular actions of insulin
2. Protein-protein interaction in insulin signalling and the molecular mechanisms of insulin resistance
3. Signaling mechanisms that regulate glucose transport
4. Membrane-permeant esters of phosphatidylinositol 3,4,5-triphosphate
5. Dual role of phosphatidylinositol-3,4,5-triphosphate in the activation of protein kinase B
6. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-triphosphate-dependent activation of protein kinase B
7. SIP/SHIP inhibits Xenopus oocyte maturation induced by insulin and phosphatidylinositol 3-kinase
8. An SH2 domain-containing 5′ inositolphosphatase inhibits insulin-induced GLUT4 translocation and growth factor-induced actin filament rearrangement
9. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling
10. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes
11. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase
12. P150ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity
13. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB
14. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling
15. The inositol 5′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation
16. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP
17. The lipid phosphatase SHIP2 controls insulin sensitivity
18. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
19. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis
20. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
21. The role of glycogen synthase kinase 3β in insulin-stimulated glucose metabolism
22. A novel SH2-containing phosphatidylinositol 3,4,5-triphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells
23. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes
24. Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling
25. The regulation of glycogen synthase by protein phosphatase 1 in 3T3-L1 adipocytes: Evidence for a potential role for DARPP-32 in insulin action
26. The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells
27. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein
28. Characterization of a 3 phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα
29. Role of translocation in the activation and function of protein kinase B
30. p85/p110-type phosphatidylinositol kinase phosphorylates not only the D-3, but also the D-4 position of the inositol ring
31. 5′ phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells
32. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: Evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf
33. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action
34. The tumor suppressor, PTEN / MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate
35. Negative regulation of PKB / Akt-dependent cell survival by the tumor suppressor PTEN